Press Releases on May 29, 2020 - EIN Presswire - Press Release Distribution Service

Published on May 29, 2020 - 12:06 GMT

Ceramic Tiles Market Size Worth USD 82.83 Billion by 2026; Rising Demand for Enhanced Home Interiors to Prove Beneficial for the ...

Pune, May 29, 2020 (GLOBE NEWSWIRE) -- The global ceramic tiles market size is projected to reach USD 82.83 billion by 2026, exhibiting a CAGR of 4.7% during the forecast period. Rapid growth in the global construction industry will augur well for this …

Distribution channels:

Published on May 29, 2020 - 12:06 GMT

Mondelēz International Participates in JDE Peet’s IPO; Retains Significant Stake

Mondelēz International contributed to JDE Peet’s successful listing on Euronext Amsterdam Company will retain two board seats at the global coffee and tea company on listing CHICAGO, May 29, 2020 (GLOBE NEWSWIRE) -- Mondelēz International, Inc. (NASDAQ: …

Distribution channels: Banking, Finance & Investment Industry, Food & Beverage Industry ...

Published on May 29, 2020 - 12:05 GMT

NextCure Presents Biomarker Data and Updated Clinical Results from Phase 1 Portion of its NC318 Clinical Trial at the 2020 Virtual ...

BELTSVILLE, Md., May 29, 2020 (GLOBE NEWSWIRE) -- NextCure, Inc. (Nasdaq: NXTC), a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class immunomedicines to treat cancer and other immune-related diseases, …

Distribution channels: Media, Advertising & PR, Technology ...

Published on May 29, 2020 - 12:05 GMT

Charles & Colvard Appoints Don O'Connell as President and Chief Executive Officer

RESEARCH TRIANGLE PARK, N.C., May 29, 2020 (GLOBE NEWSWIRE) -- Charles & Colvard, Ltd. (Nasdaq: CTHR), (the “Company”), the original and leading worldwide source of created moissanite, announced today that its Board of Directors appointed Don O’Connell …

Distribution channels: Companies, Retail ...

Published on May 29, 2020 - 12:05 GMT

Affimed Highlights Study Design of its AFM13 REDIRECT Trial at the ASCO 2020 Virtual Meeting

REDIRECT is a Registration-directed Phase II Open-label Multicenter Study to Assess the Efficacy and Safety of AFM13 in Patients with Relapsed or Refractory CD30 positive Peripheral T-cell Lymphoma or Transformed Mycosis Fungoides (REDIRECT) Heidelberg, …

Distribution channels: Technology

Published on May 29, 2020 - 12:05 GMT

Kiadis announces new data related to its K-NK cell therapy platform presented today at the ASCO 2020 Virtual Annual Meeting

A poster presentation (abstract 3025) demonstrates results of multiple FC21-NK infusions in R/R AML patients with CNS disease, treated in an investigator-initiated Phase I/II study An abstract accepted for publication (abstract e15018) presents pre- …

Distribution channels: Media, Advertising & PR, Technology ...

Published on May 29, 2020 - 12:02 GMT

CytomX Therapeutics Clinical Programs Highlighted at American Society of Clinical Oncology ASCO20 Virtual Scientific Program

- First Presentation of Clinical Data for CX-2029, a Probody Drug Conjugate, Directed Against CD71: A Previously Undruggable Target - - Data Updates for CX-2009 Support Phase 2 Investigations in Breast Cancer - - Favorable Tolerability Profile …

Distribution channels: Healthcare & Pharmaceuticals Industry, Media, Advertising & PR ...

Published on May 29, 2020 - 12:02 GMT

ITFirms Applauds Top Full Stack Developers 2020

ITFirms Lists: Best Full Stack specialists for hire in 2020! INDIA, May 29, 2020 /⁨EINPresswire.com⁩/ -- Full-stack developers understand the in and out of the project they work upon. Right from presentation layer with a typical front-end tech stack of …

Distribution channels: Business & Economy, Companies ...

Published on May 29, 2020 - 12:01 GMT

Iovance Presents Updated Clinical Data for Tumor Infiltrating Lymphocyte (TIL) Therapy Lifileucel in Advanced Melanoma at ASCO ...

Median Duration of Response Not Reached at 18.7 Months of Median Study Follow Up 36.4% Overall Response Rate (ORR) Maintained SAN CARLOS, Calif., May 29, 2020 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a late-stage biotechnology …

Distribution channels: Media, Advertising & PR, Technology ...